Every day, countless people across America order prescription drugs from pharmacies in other countries as they hunt for something increasingly elusive — affordable medications.

But there’s a problem. Under most circumstances, importing medicines is illegal.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I appreciate Mr. Levitt’s gracious apology and reply. Would that more of our public discourse were characterized by courtesy of this kind.

    • Dear Ron and Gabe,

      This is a belated thanks for sharing your thoughts on a difficult topic. I believe you both make valid points that are worth considering if the matter is to be pursued. I’ve said my piece for now, so will leave it at that.

      All best,
      ed at pharmalot

  • A final point: in the end, the price of a drug, or of any healthcare service, should bear a relationship to its value. The cost of all healthcare in the US is far higher than in other countries–this includes the costs of office visits, diagnostics, devices, surgeries, hospitalizations, etc., and drugs are no more costly relative to, say, Canada or the EU, than are these other healthcare goods and services. Our system defaults to paying for volume rather than for outcomes. We should be striving to shift our entire system to one that pays for value and better health outcomes, rather than by the piece.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy